Lirilumab (Anti-KIR)

Ask supplier a question | View on supplier's website

Lirilumab (Anti-KIR) is a fully human monoclonal antibody against killer-cell immunoglobulin-like receptors (KIR), with potential antineoplastic activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. MW: 150 kD.

Supplier	Selleck Chemicals
Product #	A2419
Sku #	A2419-1mg
Pricing	1mg, $370.00

Feedback